Researchers at McMaster University have discovered a critical vulnerability in drug-resistant bacteria: zinc - or a lack thereof.

University of Montana Dr. Blair DeBuysscher Dr. Andrea Stierle Through the I-RED ASCEND2.0 Program, Dr. Blair DeBuyssche ...

Researchers at McMaster University have discovered a critical vulnerability in drug-resistant bacteria: zinc—or a lack ...

Chicago antibiotic discovery lab engages middle school students from underrepresented communities in hands-on research ...

APPA-02 is under development for the treatment of multidrug-resistant chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients and non-CF bronchiectasis (NCFB). The drug ...

Fenretinide is under clinical development by Laurent Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Researchers at the Indian Institute of Technology (IIT) Bombay have made a groundbreaking discovery in environmental science. They've identified bacteria that can consume toxic pollutants in the soil ...

A dry eye drop recall has been issued due to the discovery of fungal material, but no adverse events have been reported.

and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare ...

Pseudomonas bacteria are commonly found in soil and water, and can cause serious, even deadly, infections in those with weakened immune systems, external medical devices or underlying lung conditions, ...

Researchers at the John Innes Centre have discovered that the capacity of bacteria to spread disease in plants is more extensive than known before. Using Pseudomonas syringae, they found that the ...